Centene stock uncertainty as ACA subsidy expiration looms: What investors need to know about rising medical costs and 2026 Marketplace risk
via fortune.com
Short excerpt below. Read at the original source.
Centene‘s stock has experienced a significant decline—more than 42% in the past six months—primarily due to the withdrawal of its 2025 financial guidance following some troubling developments in its core health insurance business. Centene’s recent stock drop is closely linked to a combination of higher-than-expected medical costs amid challenging trends in the Affordable Care Act […]